Cosmos Health Inc (NASDAQ: COSM)’s stock price has gone decline by -4.33 in comparison to its previous close of 0.93, however, the company has experienced a 29.37% increase in its stock price over the last five trading days. accessnewswire.com reported 2025-01-22 that CHICAGO, IL / ACCESS Newswire / January 22, 2025 / Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has secured buy-out rights and exclusive licensing for two patented anticancer drugs targeting, among others, prostate, ovarian, and colorectal cancers. Both of these innovative anticancer therapies, developed through cutting-edge oncology research, are protected by international patents and set to commence Clinical Phase I trials.
Is It Worth Investing in Cosmos Health Inc (NASDAQ: COSM) Right Now?
Moreover, the 36-month beta value for COSM is 3.19. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for COSM is 18.22M and currently, short sellers hold a 2.95% of that float. On January 22, 2025, COSM’s average trading volume was 315.67K shares.
COSM’s Market Performance
COSM stock saw an increase of 29.37% in the past week, with a monthly gain of 35.62% and a quarterly increase of 12.28%. The volatility ratio for the week is 18.02%, and the volatility levels for the last 30 days are 12.18% for Cosmos Health Inc (COSM). The simple moving average for the last 20 days is 25.88% for COSM’s stock, with a simple moving average of 5.52% for the last 200 days.
COSM Trading at 23.15% from the 50-Day Moving Average
After a stumble in the market that brought COSM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.69% of loss for the given period.
Volatility was left at 12.18%, however, over the last 30 days, the volatility rate increased by 18.02%, as shares surge +42.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +29.79% upper at present.
During the last 5 trading sessions, COSM rose by +27.96%, which changed the moving average for the period of 200-days by +27.54% in comparison to the 20-day moving average, which settled at $0.7063. In addition, Cosmos Health Inc saw 32.99% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COSM starting from Siokas Grigorios, who purchase 29,158 shares at the price of $0.86 back on Jan 17 ’25. After this action, Siokas Grigorios now owns 4,164,789 shares of Cosmos Health Inc, valued at $25,000 using the latest closing price.
Siokas Grigorios, the Chief Executive Officer of Cosmos Health Inc, purchase 47,904 shares at $0.83 during a trade that took place back on Jan 16 ’25, which means that Siokas Grigorios is holding 4,135,631 shares at $40,000 based on the most recent closing price.
Stock Fundamentals for COSM
Current profitability levels for the company are sitting at:
- -0.36 for the present operating margin
- 0.08 for the gross margin
The net margin for Cosmos Health Inc stands at -0.36. The total capital return value is set at -0.51. Equity return is now at value -46.31, with -26.60 for asset returns.
Based on Cosmos Health Inc (COSM), the company’s capital structure generated 0.24 points at debt to capital in total, while cash flow to debt ratio is standing at -0.33. The debt to equity ratio resting at 0.32. The interest coverage ratio of the stock is -19.59.
Currently, EBITDA for the company is -17.06 million with net debt to EBITDA at -0.42. When we switch over and look at the enterprise to sales, we see a ratio of 0.51. The receivables turnover for the company is 3.21for trailing twelve months and the total asset turnover is 0.87. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.
Conclusion
To wrap up, the performance of Cosmos Health Inc (COSM) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
